|
End-of-day quote
Korea S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 53,100.00 KRW | -1.30% |
|
-5.68% | -55.75% |
| 08-23 | Orum Therapeutics Receives FDA Clearance Of IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate | CI |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | -5.68% | -14.22% | -15.04% | -55.75% | +71.01% | - | - | - | 872M | |
| -0.25% | -0.96% | -0.21% | +65.28% | +70.45% | +45.25% | +102.76% | +9.75% | - | 68.52B | |
| -1.09% | -4.97% | +12.13% | +12.90% | +19.39% | +31.10% | +76.56% | +202.40% | +5,822.49% | 62.88B | |
| -1.18% | +0.51% | -2.91% | +28.51% | -26.87% | -13.53% | +384.69% | +352.31% | +865.71% | 28.13B | |
| -2.74% | -3.53% | +3.58% | +58.65% | +51.08% | +26.13% | +13.50% | -60.35% | - | 25.56B | |
| -1.76% | -7.14% | +2.91% | +11.45% | +1.26% | -5.57% | -19.75% | -72.57% | - | 24.65B | |
| -2.39% | -4.23% | +4.20% | +29.34% | +2.76% | +18.42% | -20.95% | -27.14% | +108.30% | 19.81B | |
| -1.86% | +1.15% | +6.45% | +47.90% | +211.54% | +205.44% | +353.89% | +1,664.30% | +812.88% | 17.69B | |
| -1.37% | -3.77% | -12.07% | +22.46% | +20.96% | -9.38% | +528.34% | - | - | 14.66B | |
| -1.54% | -1.88% | +6.21% | +8.38% | +31.03% | +50.03% | +159.75% | +193.91% | +379.38% | 14.45B | |
| -3.08% | +16.44% | +21.78% | +18.96% | -2.80% | -9.69% | +1,003.90% | +157.97% | +175.08% | 13.99B | |
| -2.48% | -2.53% | +4.53% | +11.79% | -8.45% | +18.81% | +171.20% | +565.48% | +4,715.90% | 12.63B | |
| +0.16% | -3.06% | -5.58% | +12.86% | +24.66% | +198.45% | +176.79% | +26.76% | +1,055.87% | 11.67B | |
| -1.53% | +6.61% | -6.40% | +4.64% | -17.17% | -33.19% | +170.91% | +118.95% | - | 11.16B | |
| -0.66% | +2.35% | -4.09% | +7.55% | +15.86% | +42.95% | +104.16% | +144.99% | +709.90% | 10.3B | |
| -1.03% | -4.35% | +1.43% | +25.64% | +27.65% | +80.01% | +16.22% | +126.63% | - | 8.86B | |
| -4.22% | -2.89% | +1.05% | +6.48% | +289.90% | +200.39% | +498.45% | -22.41% | - | 8.54B | |
| -3.69% | -6.42% | -13.74% | +7.44% | +3.33% | -28.74% | +123.42% | -29.81% | - | 8.26B | |
| +2.05% | +1.91% | -15.44% | +16.05% | +170.79% | +429.93% | +533.64% | -50.02% | -48.94% | 7.66B | |
| -4.42% | +8.97% | +7.37% | +23.79% | +9.45% | +166.55% | +455.60% | - | - | 7.38B | |
| Average | -1.71% | +1.01% | -0.15% | +20.25% | +41.95% | +74.22% | +254.37% | +194.18% | +1,459.66% | 18.88B | |
| Weighted average by Cap. | -1.44% | +0.09% | +2.53% | +29.31% | +40.70% | +50.44% | +192.56% | +181.71% | +2,478.31% |
- Stock Market
- Stocks
- A475830 Stock
- Sector Orum Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
